Erin Collins

Erin Collins is an experienced professional in the field of regulatory affairs, currently serving as the Director of Clinical Regulatory Affairs at Vera Therapeutics, Inc. Previously, Erin held the position of Director of Regulatory Affairs at both Sumitomo Pharma America, Inc. and Urovant Sciences, Inc., demonstrating extensive expertise in managing regulatory processes and compliance within the pharmaceutical industry.